Top Stocks For 2018

A better-than-expected second quarter helped to propel Global Payments (GPN) to the top of the S&P 500 on Monday. The payment technology firm also updated its forecast and increased its share repurchase program.

Mark Wilson/Getty Images

Global Payments climbed 7.2%, or $5.34, to $79.79 on the news, putting it close to its 52-week high of $80.88. Its up 15% year to date and nearly 37% in the past year.

Evercore ISIs David Togut raised his price target by $4, to $96 following the news, along with his earnings estimates:

For 2Q/FY17, cash EPS grew 17% to $0.89, or 22% on a constant currency basis, $0.01 above our above-consensus forecast after adjusting for below the line items, such as a lower than expected tax rate. Meanwhile, adjusted net revenue grew 61% in constant currency to $817 million, $16 million ahead of our forecast. Adjusted EBIT grew 57% to $241 million, $4 million above our estimate and corresponding margin declined 10 basis points to 29.5%, 20 basis points below our estimateRaising FY17 EPS by $0.05 to $3.54 largely given the 2Q/17 earnings outperformance. Increasing FY18 EPS estimate by $0.07 to $4.35 driven by the $10 million increase in synergies anticipated from the Heartland merger and a lower tax rate estimate, partially offset by a lower forecast for Europe margin given increased FX headwinds.

Top Stocks For 2018: Hot Tech Stocks To Own For 20()

Advisors’ Opinion:

  • [By ]

    For example, say Remind my wife about the party and say don’t forget to pick up a bottle of red wine tonight. Siri will know who your spouse is (or will ask you once) and place that in the To: field, and because you said about the party, Siri knows you want that in the Subject (Re:) field. You also said and say, which places words you said after that into the body of the email. This will all save you time!

  • [By Max Byerly]

    (CURRENCY:) traded flat against the US dollar during the 24 hour period ending at 8:00 AM E.T. on April 18th. In the last seven days, has traded flat against the US dollar. One coin can currently be purchased for about $0.0000 or 0.00000000 BTC on exchanges including 295

Top Stocks For 2018: Westport Innovations Inc(WPRT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Westport Fuel Systems Inc (USA) (NASDAQ: WPRT) shares were also up, gaining 16 percent to $3.48 on upbeat Q3 results.

    Equities Trading DOWN

  • [By Jason Hall]

    Furthermore, having a strong financial partner in Total to help it drive adoption of heavy-duty natural gas vehicles at this time could be a huge win. Prices of oil (and therefore diesel) have been steadily climbing over the past year, and the highly anticipated near-zero-emissions natural gas engine fromCummins(NYSE:CMI) andWestport Fuel Systems(NASDAQ:WPRT) is now being shipped to customers.

  • [By Daniel Miller]

    Shares of Westport Fuel Systems (NASDAQ:WPRT), a provider of high-performance, low-emission engine and fuel systems, are down 10% as of 11:20 a.m. EDT after the company reported its first-quarter results.

Top Stocks For 2018: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Smith & Wesson’s (SWHC) stock has been under pressure ever since Donald Trump’s election victory–it appears that the perceived threat to take away guns did wonders for the gun manufacturer’s sales. Now, Smith & Wesson might also have to deal with competitive pressures that could “challenge” its market share, says Wunderlich’s Rommel Dionisio:

    Getty Images

    Given the upcoming mid-January Shot Show, the firearms industrys most important annual trade show, several prominent competitors have already begun to unveil new products for 2017. The flurry of major new product introductions from leading players in the field into the two fastest growing categories of firearms, modern sporting rifles (MSRs) and compact/concealed carry handguns, appear meaningfully more competitive than usual, which could challenge Smith & Wessons (SWHC) market share, which had been rising impressively the past several years. Industry sales are also likely to slow, following unusually high growth in 2016. We maintain our price target of $26, derived using an EV/2016E EBITDA multiple of 6.0x.

    Shares of Smith & Wesson have dropped 1.5% to $21.78 at 12:07 p.m. today.

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming volatile higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker TASER International, Inc (NASDAQ: TASR):

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.

  • [By Peter Graham]

    A long term performance chart shows TASER Internationaloutperforming and all over the place while police body cam stockDigital Ally, Inc (NASDAQ: DGLY)has underperformed, Mace Security International (OTCMKTS: MACE) has been moving sideways and gun stock Sturm, Ruger & Company (NYSE: RGR) has underperformedAmerican Outdoor Brands Corp(NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC):

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile and higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

Top 10 Blue Chip Stocks To Invest In 2019

Shutterstock

Dont take any dividends for granted today. Business disruption is accelerating as entire industries are being eaten alive.

Uber and Lyft? Killed cabs.

Amazon (AMZN)? Its crushing retail, and starving their REIT landlords right before our very eyes.

And soon, they might team up to offer more same day deliveries and make more rivals obsolete!

These types of disturbances have added a new layer to contrarian investing. Before, it was as simple as buying stocks when they were out-of-favor and holding them until they became back in vogue. The Dogs of the Dow strategy, for example, usually beat the market by banking the highest blue chip dividend yields a sign that the tide was ready to turn back in the dogs favor.

Top 10 Blue Chip Stocks To Invest In 2019: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Blue Chip Stocks To Invest In 2019: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 3.8% Thursday to post a new 52-week low of $2.28. Shares closed at $2.37 on Wednesday and the stock’s 52-week high is $4.25. Volume was about 15% below the daily average of around 5.9 million shares. The company had no specific news.

Top 10 Blue Chip Stocks To Invest In 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Stephen Mack]

    Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.

Top 10 Blue Chip Stocks To Invest In 2019: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Chris Lange]

    Lululemon Athletica Inc. (NASDAQ: LULU) will report its most recent quarterly results on Wednesday as well. The consensus estimates are EPS of $0.52 and $609.71 million in revenue. Shares traded at $67.22 on Friday, in a 52-week range of $47.26 to $72.70. The consensus price target is $65.50.

  • [By Chris Lange]

    Lululemon Athletica Inc. (NASDAQ: LULU) is set to release its most recent quarterly results on Tuesday. The consensus forecast calls for $1.27 in EPS and $911.42 million in revenue. Shares traded on Fridays close at $79.51. The consensus price target is $84.33, and the 52-week range is $47.26 to $83.98.

  • [By Lisa Levin]

    Shares of Lululemon Athletica inc. (NASDAQ: LULU) got a boost, shooting up 15 percent to $68.99 after the company reported stronger-than-expected earnings for its third quarter and announced a $100 million stock buyback plan.

  • [By Peter Graham]

    Athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU) reported Q2 2017 earnings after the Thursday market close with results toppingexpectations as online sales surged 30% after an effort to beef up the eCommerce strategy plus the Company raised its outlook. Net revenuegrew 13% to$581.1 millionas total comparable sales increased 7% and comparable store sales increased 2%, or increased by 2% on a constant dollar basis. Direct to consumer net revenue increased 29%, or increased 30% on a constant dollar basis. During the quarter the Company held an online warehouse sale. Excluding the impact of this sale, direct to consumer net revenue increased 15%, or increased 16% on a constant dollar basis. Net income was $48.711 million versus net income of $53.625 million. The Company ended the second quarter of fiscal 2017 with $721.2 million in cash and cash equivalents compared to $535.3 million at the end of the second quarter of fiscal 2016. The CEO commented:

  • [By Paul Ausick]

    Lululemon Athletica Inc. (NASDAQ: LULU) reported fiscal second-quarter 2017 results after markets closed Thursday afternoon. The yoga gear maker reported adjusted diluted earnings per share (EPS) of $0.39 on revenues of $581.1 million, compared with EPS of $0.38 on revenues of $514.5 million in the same period a year ago. The consensus estimates called for EPS of $0.35 on revenues of $567.6 million.

  • [By Peter Graham]

    Athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU)reported earnings for the first quarter ended April30, 2017along witha plan to restructure its ivivva operations. Net revenuerose 5% to$520.3 millionas total comparable sales decreased 1% whiledirect to consumer net revenue was flat. Net income was $31.246 million versus $45.336 million. In addition, the earnings report stated:

Top 10 Blue Chip Stocks To Invest In 2019: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.20, with a consensus price target of $57.11 and a 52-week range of $15.97 to $40.65.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Blue Chip Stocks To Invest In 2019: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today as weakness that began last month even before its fourth-quarter earnings continued into year end.

    Agence France-Presse/Getty Images

    Mallinckrodtdropped 2.7% to $51.77 today, while the S&P 500 rose 0.2% to 2,268.88.

    Mallinckrodt was the biggest loser in the S&P 500 for two consecutive days in mid-November, and again after reporting its earnings.

    Mallinckrodt’s market capitalization fell to $5.5 billion today from $5.6 billion yesterday. It reported net income of $489 million on sales of $3.38 billion in fiscal 2016.

    Mallinckrodt has dropped 31% so far this year.

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after Citron Research accused the company of fraud.

    Getty Images

    Mallinckrodt tumbled 12% to $59.60 today, while the S&P 500 declined 0.2% to 2,176.94.

    Leerink’s Jason Gerberry and Etzer Darout explain the allegations:

    Mallinckrodtshares are down -7-8% based on a short report citing CMS dashboard data which call into question Acthar Gel sales derived from government sources (CMS; Medicaid & Medicare). The report appears to overstate Acthar CMS sales as a percent of total product sales, as the methodology utilized by CMS drug spending dashboard for Medicare spend is based on gross sales, not net., although it’s unclear to what extent Acthar CMS sales are overstated.

    The report suggestsMallinckrodt mgmt understated combined Medicaid/Medicare sales on an investor call, saying it was about a little bit higher than a quarter of the business vs. gross sales on CMS dashboard implying sales were 61% of total Acthar net revenue (an apples to oranges comparison). We dont know the exact net sales of Acthar to Medicare/Medicaid, but we believe it is safe to assume Medicaid, after CPI price penalties had high discounts/rebates and assuming an 80% gross-to-net ratio on the Medicare book ($504m gross) suggests Acthar net sales would be closer to 38-45% range vs. the 61% figure cited in the short-report. Why this may matter Acthar Gel is an old product lacking good randomized, controlled data consistent with most products approved in the modern era. The report appears to be an attempt to call into question whether the government should be paying Acthars average $80-100k net price/patient/year by calling to this to the attention of government figures who have been targeting excessive drug pricing issues. This type of issue became a major headache for Mylan (MYL) investors recently with EpiPen.Mallinckrodt is presenting at a compe

Top 10 Blue Chip Stocks To Invest In 2019: Apollo Education Group, Inc.(APOL)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap for-profit education stock Apollo Education Group Inc (NASDAQ: APOL) is scheduled for after the market closes on Monday (January 9th). Last February, Apollo Education Groupannounced a definitive agreement to be acquired by a consortium of investors including The Vistria Group, LLC, funds affiliated with Apollo Global Management, LLC (NYSE: APO), and Najafi Companies for $9.50 per share in cash for both Class A and B shares. However, the for-profit education sector along with certain aspects of the Apollo deal have been targeted by the Obama administration and it remains to be seen how the Trump administration will treat the sector and the deal.

Top 10 Blue Chip Stocks To Invest In 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By CNBC]

    Tony Tribble, Invision/AP
    Forget about Bloomin’ Onions or boneless wings, for many consumers, the choice of where to dine often comes down to a different factor: which restaurant has the best booze.
    “Alcoholic beverages can be a key driver of traffic, differentiation, and loyalty,” said David Decker, president of Consumer Edge Insight. According to the firm, two factors that keep customers coming back are “selection” and “pricing.”
    Consumer Edge Insight recently surveyed restaurant customers to find out which casual-dining spots generated the most loyalty with their alcoholic beverages.
    Taking the top spot for “selection” was Buffalo Wild Wings (BWLD), with 29 percent of those surveyed saying they were “most likely to visit it most often due to its good selection of alcoholic beverages.”
    Applebee’s (DIN) took the second spot, with 24 percent, and Outback Steakhouse (BLMN) and T.G.I. Friday’s tied for third place with 22 percent each.
    Prices also keep customers coming back to Buffalo Wild Wings.

    When asked which casual-dining brand they were “most likely to visit most often due to its good prices of alcoholic beverages,” Buffalo Wild Wings came out on top with 30 percent. Chili’s (EAT) was No. 2 at 23 percent, and Ruby Tuesday (RT) was third with 22 percent.
    Buffalo Wild Wings has always made alcohol a part of its experience, even making it part of its tagline: “Wings.Beer.Sports.”
    The chain is the No. 1 account for more than 50 different beer brands and recently launched Game Changer, a new beer in a partnership with Redhook Brewery. Priced between cheaper domestic lagers and pricier craft beers, Game Changer became the fourth-most-popular draft beer at company-owned locations within two weeks of its release.
    “Among casual-dining restaurants, Buffalo Wild Wings is seeing the greatest positive effect in terms of building customer loyalty with its alcohol offerings,” Decker said. “There are many steps other restaurants can take to improve their alcoho

Top 10 Blue Chip Stocks To Invest In 2019: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

Top 10 Blue Chip Stocks To Invest In 2019: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming volatile higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker TASER International, Inc (NASDAQ: TASR):

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile and higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Lisa Levin]

    Shares of Smith & Wesson Holding Corp (NASDAQ: SWHC) were down 12 percent to $21.04. Smith & Wesson reported upbeat results for its second quarter, but issued a weak outlook for its third quarter.

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile but higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.

Best Performing Stocks For 2018

Treasury yields trimmed their decline on Tuesday but still ended lower after stocks rebounded from the previous days rout that drew investors into perceived safe havens and pushed bond prices higher.

How are Treasurys performing?

The yield on 10-year Treasury notes
TMUBMUSD10Y, +3.58%
fell 2.8 basis points to 2.766%, after having fallen as low as 2.648%. The benchmark yield had risen to a four-year high of 2.883% on Monday.

Best Performing Stocks For 2018: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Best Performing Stocks For 2018: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Lee Jackson]

    Icahn also was a buyer last week of Navistar International Corp. (NYSE: NAV). He acquireda total of 423.404 shares of the truck and engine maker at prices that ranged from $25.37 to $25.92. The total for the buy was listed at $11 million. The stock closed Friday at $27.49, so it looks like another well-timed buy. The 52-week range for the shares is $10.30 to $33.46, and the consensus price target is $26.79.

  • [By Lee Jackson]

    Navistar International Corp. (NYSE: NAV) was started with a Buy rating and a $36 price objective at Aegis Capital. That compares with a consensus target of $24.08. The 52-week range is $5.78 to $32.84. The stock closed yesterday at $30.93.

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

Best Performing Stocks For 2018: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows TASER Internationaloutperforming and all over the place while police body cam stockDigital Ally, Inc (NASDAQ: DGLY)has underperformed, Mace Security International (OTCMKTS: MACE) has been moving sideways and gun stock Sturm, Ruger & Company (NYSE: RGR) has underperformedAmerican Outdoor Brands Corp(NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC):

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile but higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Lisa Levin]

    Shares of Smith & Wesson Holding Corp (NASDAQ: SWHC) were down 12 percent to $21.04. Smith & Wesson reported upbeat results for its second quarter, but issued a weak outlook for its third quarter.

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.

Best Performing Stocks For 2018: Diana Containerships Inc.(DCIX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Diana Containerships Inc (NASDAQ: DCIX) shares shot up 45 percent to $9.60. Diana Containerships reported a Q3 loss of $128.67 per share on sales of $6.73 million.

  • [By Lisa Levin]

    Diana Containerships Inc (NASDAQ: DCIX) shares shot up 109 percent to $13.78. Diana Containerships reported a Q3 loss of $128.67 per share on sales of $6.73 million.

  • [By Wayne Duggan]

    DryShips isn’t the only shipping stock that has skyrocketed this month; the following stocks’ shares are all up between 320 and 720 percent since November 2:

    Diana Containerships Inc (NASDAQ: DCIX). Euroseas Ltd. (NASDAQ: ESEA). Globus Maritime Ltd (NASDAQ: GLBS). Sino-Global Shipping America, Ltd. (NASDAQ: SINO).

    One of the primary reasons for the extreme moves in DryShips and other shipping stocks is a combination of large short positions in the stocks and extremely low share counts. DryShips in particular lowered its share count from around 672 million to only around 1 million via a series of reverse stock-splits throughout the year. The splits were intended to allow the stock to maintain its Nasdaq listing after it had lost more than 98 percent of its value in the first 10 months of 2016.

  • [By Lisa Levin]

    Shares of Diana Containerships Inc (NASDAQ: DCIX) were down 8 percent to $0.433. Diana Containerships reported a Q1 loss of $0.80 per share on sales of $3.77 million.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top 10 Warren Buffett Stocks To Invest In Right Now

Billionaire investor Warren Buffett is getting richer by the minute.

That’s because the Oracle of Omaha’s company Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B) has a portfolio full of dividend-yielding stocks.

Represented are Wells Fargo & Co. (NYSE: WFC), Coca-Cola Co. (NYSE: KO), and Kraft Heinz Co. (Nasdaq: KHC), just to name a few.

The Berkshire portfolio has 34 dividend stocks in total; of those, eight yield dividend returns in excess of 3% annually, according to Buffett’s latest SEC 13F filing on Feb. 14, 2017.

Top 10 Warren Buffett Stocks To Invest In Right Now: Lennox International, Inc.(LII)

Advisors’ Opinion:

  • [By Greg Williamson]

    Watsco’s current P/E of 24.5 is in the same ballpark as its competitor Lennox International (NYSE: LII  ) (NYSE: LII  ) (NYSE: LII  ) , whose P/E is 23.8. Lennox is a manufacturer of HVAC equipment and components, and will also benefit from HVAC industry tailwinds.

Top 10 Warren Buffett Stocks To Invest In Right Now: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

Top 10 Warren Buffett Stocks To Invest In Right Now: Pilgrim's Pride Corporation(PPC)

Advisors’ Opinion:

  • [By John Udovich]

    Thanksgiving is almost here but the exit of both Pilgrim’s Pride Corporation (NYSE: PPC) and Smithfield Foods (NYSE: SFD) to focus on their chicken or pork businesses (the latter was also acquired by the Chinese) leaves just two big Thanksgiving turkey stocks, Hormel Foods Corporation (NYSE: HRL) and Seaboard Corporation (NYSEAMEX: SEB), for investors to consider. According to the American Far Bureau, a 16-pound turkey will (on average) come in at a total of $22.74 this year or roughly $1.42 per pound for a decrease of 2 cents per pound or a total of 30 cents per whole turkey, compared to 2015. The price drop may be a transition back to the norm as the significant bird flu outbreak last year hurt the nations supply of both turkey and eggs.

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanderson Farms doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit shares are below their peaks and have been somewhat volatile:

  • [By Peter Graham]

    The Q4 2016earnings report for mid cap chicken producer Pilgrim’s Pride Corporation (NASDAQ: PPC) scheduled for before the market opens on Thursday(February 9th). Pilgrim’s Pride Corporationis the sixth most shorted stock on the Nasdaq with short interest of 41.76%according to Highshortinterest.com. Theelevated short interest comes in the wake of the worstbird-flu outbreak in the US whichhad hurt demand and triggered import bans abroad.

  • [By Peter Graham]

    Mid cap chicken producer Pilgrim’s Pride Corporation (NASDAQ: PPC) reportedQ2 2017 earnings after the market closed Wednesday as short interest remains elevated at 31.17%according to Highshortinterest.comin the wake of the worstbird-flu outbreak in the US whichhad hurt demand and triggered import bans abroad. Net sales were up 11.0% to $2.252 billion while net income attributable to Pilgrim’s Pride Corporation was $233.641 million versus $152.886 million.The earnings release noted:

  • [By Peter Graham]

    A long term performance chart shows shares ofmid cap Sanderson Farms more than doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit shares are below previous highs and have been somewhat volatile:

  • [By Peter Graham]

    A long term performance chart shows Bob Evans Farms breaking out while a comparison to possible peers in the remaining core business shows the stock had underperformed large caps Hormel Foods Corporation (NYSE: HRL) andTyson Foods, Inc (NYSE: TSN) and mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) when it was still in the restaurant business:

Top 10 Warren Buffett Stocks To Invest In Right Now: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

Top 10 Warren Buffett Stocks To Invest In Right Now: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Smith & Wesson’s (SWHC) stock has been under pressure ever since Donald Trump’s election victory–it appears that the perceived threat to take away guns did wonders for the gun manufacturer’s sales. Now, Smith & Wesson might also have to deal with competitive pressures that could “challenge” its market share, says Wunderlich’s Rommel Dionisio:

    Getty Images

    Given the upcoming mid-January Shot Show, the firearms industrys most important annual trade show, several prominent competitors have already begun to unveil new products for 2017. The flurry of major new product introductions from leading players in the field into the two fastest growing categories of firearms, modern sporting rifles (MSRs) and compact/concealed carry handguns, appear meaningfully more competitive than usual, which could challenge Smith & Wessons (SWHC) market share, which had been rising impressively the past several years. Industry sales are also likely to slow, following unusually high growth in 2016. We maintain our price target of $26, derived using an EV/2016E EBITDA multiple of 6.0x.

    Shares of Smith & Wesson have dropped 1.5% to $21.78 at 12:07 p.m. today.

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile and higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile but higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Diane Alter]

    Shareholders “overwhelmingly” voted to change the company name from Smith & Wesson Holding Corp. (Nasdaq: SWHC) to American Outdoor Brands Corp., the Springfield, Mass.-based company said in a statement Tuesday. The proposed name change was approved by Smith & Wesson’s board of directors last month.

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.

  • [By Peter Graham]

    A long term performance chart shows TASER Internationaloutperforming and all over the place while police body cam stockDigital Ally, Inc (NASDAQ: DGLY)has underperformed, Mace Security International (OTCMKTS: MACE) has been moving sideways and gun stock Sturm, Ruger & Company (NYSE: RGR) has underperformedAmerican Outdoor Brands Corp(NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC):

Top 10 Warren Buffett Stocks To Invest In Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Top 10 Warren Buffett Stocks To Invest In Right Now: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    For many years, NVIDIA (NASDAQ:NVDA) has relied on Taiwan Semiconductor Manufacturing Company (NYSE:TSM) to manufacture the graphics chips it designs. Today, most of NVIDIA’s Pascal architecture-based graphics processors — from the GeForce GTX 1060, designed for mainstream PC gamers, all the way through its cutting edge Tesla P100 datacenter accelerators — are manufactured by TSMC.

  • [By Ashraf Eassa]

    To illustrate my point, Intel’s chief competitor, Taiwan Semiconductor Manufacturing Company (NYSE:TSM), has said that its 7-nanometer technology, which should go into mass production in the first half of 2018, delivers a roughly 1.63-fold density improvement over its 10-nanometer technology.

  • [By Ashraf Eassa]

    Contract-chip manufacturing giant Taiwan Semiconductor Manufacturing Company (NYSE:TSM) recently announced its earnings results, provided forward guidance for the current quarter, and provided a lot of insight on the ramp-up of its next-generation chip-manufacturing technology, called 10-nanometers (10nm for short).

  • [By Ashraf Eassa]

    As part of this discussion, he took the time to explain how the technology that Intel calls 14 nanometers is more like what its competitors — Samsung (NASDAQOTH:SSNLF) and Taiwan Semiconductor Manufacturing Co.(NYSE:TSM) — call 10 nanometers (smaller is generally believed to be better).

  • [By Ashraf Eassa]

    A while back, DigiTimes reported that Taiwan Semiconductor Manufacturing Company (NYSE:TSM), a major contract chip manufacturer, planned to introduce an enhanced variant of its 16nm manufacturing technology dubbed “12nm.”

Top 10 Warren Buffett Stocks To Invest In Right Now: TiGenix NV (TGXSF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Leuven, Belgium-based Tigenix (OTC:TGXSF) filed to go public in the U.S. in late 2015, only to become entangled with Bavarian Nordic (OTC:BVNKF) and Basilea Pharmaceutica (OTC:BPMUF) as the European drugmakers pulled back from NASDAQ. Tigenix subsequently increased its bank account following a 23.75 million placement in Belgium, and added an additional 25 million via a relationship with Takeda, before coming back to Wall Street in October 2016 with a revamped slate of underwriters.

Top 10 Warren Buffett Stocks To Invest In Right Now: BlackBerry Limited(BBRY)

Advisors’ Opinion:

  • [By Piyush Arora]

    The point that Im trying to make is that BlackBerry is facing an acute shortage of apps, and the fixes available to mitigate the issue, are getting outdated and might not necessarily work in 2017. The company needs to do something about its BB10 OS, otherwise, its remaining base of loyal users might abandon the platform as well. (See Also: BlackBerry Stock: BlackBerry Ltd (BBRY) Might Gain From The Tesla Motors Inc Hack)

  • [By Sreekanth Anasa]

    BlackBerry’s (NSDQ:BBRY)turnaround has been moving at snail’s pace. In that context, BlackBerry’s deal with Ford (NYSE:F) to expand usage of its QNX software in the latter’s line of connected cars was welcome news. Many see BBRY’s focus on automotive technology as a potential profit center. Norwegian security firm, Promon, recently gave a demonstration of howTesla (NSDQ:TSLA) cars can be stolen by hackers through the company’s official android application, which many car owners use to interact with their vehicles. This was one of the latest unflattering events to take place for Tesla. But this very news can be good for Blackberry. Here’s why.

  • [By Lisa Levin]

    BlackBerry Ltd (NASDAQ: BBRY) reported an unexpected profit for the first quarter. However, sales trailed expectations. The company also announced a stock buyback program.

  • [By Jack Foley]

    BlackBerry(NSDQ:BBRY)stock is a very volatile stock. When the company announced its latest set of earnings on the 20th of December, the share price rose to around $8 a share, but since then has plummeted back down to the $7 level. Blackberry is unique in that it is a low priced stock but is just as liquid as many of its peers. This combined with the volatility of the tech sector attracts all types of investors and traders as volatility is a guarantee (which we have obviously seen over the past week or so).

  • [By Kumar Abhishek]

    Shares of Ontario-basedsoftware companyBlackBerry Ltd (NASDAQ:BBRY) jumped more than 16% in yesterday’s trade,creating a new 52-week highafter the company announced that it has won a windfall of $814.9 million in an interim arbitrationaward against Qualcomm (NASDAQ:QCOM).Moreover, the arbitration award is not appealable by Qualcomm. The final award which will include interest rates and legal fees will be decided on May 31st. The windfall gain has earned BBRY stock price target upgrades from several analysts. The arbitration relates to an overpayment of royalty by BlackBerry Ltd between 2010 and 2015. The question now is, does this one-time award change anything for BlackBerry Ltd stock?

  • [By Sreekanth Anasa]

    Shares of San Diego, California-based QUALCOMM, Inc. (NASDAQ:QCOM)plunged further, losing more than 3.5% in yesterday’s trade. QCOM stock is now near its lowest levels since the post-earnings sell off. QCOM stock dipped on account of the smartphone chipmaker losing an arbitration case against BlackBerry (NASDAQ:BBRY). Qualcomm was ordered to refund a sum of nearly $815M to the software company. This comes on the back of the San Diego company’s latest countersuit againstApple (NASDAQ:AAPL). QCOM stock had already been battered this year on account of its mounting legal troubles. With Qualcomm stock trading at such low levels, investors could be puzzled about whether they should buy this dip in QCOM stock.Is QCOM stock headed much lower? Will Qualcomm stock rebound ahead of its earnings? Let’s take a closer look.

Top 10 Warren Buffett Stocks To Invest In Right Now: Canon, Inc.(CAJ)

Advisors’ Opinion:

  • [By Dan Carroll]

    Nikon’s story is similar to what’s plaguing its Japanese rival, Canon (NYSE: CAJ  ) . Canon’s stock has nosedived by 20% year to date, but the stock’s recovered nearly 3% over the past month. Don’t let appearances fool you: The company slashed its full-year sales and profit forecasts back in July, as the worldwide camera market has slumped, and as smartphones continue to take over this aging niche. Canon’s route back to respectability looks like a treacherous climb.

  • [By Paul R. La Monica]

    Miscellaneous shorts. Lamensdorf is also betting against Japanese printer and camera giant Canon (CAJ) since he believes the company still hasn’t figured out a way to compete with smartphones.